EPHS Holdings, Inc., through its subsidiary, Emerald Plants Health Source Inc., produces cannabis for medical use.
Weak fundamentals or lack of information.
Share Price & News
How has EPHS Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
7 Day Return
1 Year Return
Return vs Industry: STNN underperformed the US Pharmaceuticals industry which returned -8% over the past year.
Return vs Market: STNN underperformed the US Market which returned 6.9% over the past year.
Price Volatility Vs. Market
How volatile is EPHS Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is EPHS Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Undervalued: Insufficient data to calculate STNN's fair value to establish if it is undervalued.
Significantly Undervalued: Insufficient data to calculate STNN's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: STNN is unprofitable, so we can't compare its PE Ratio to the Pharmaceuticals industry average.
PE vs Market: STNN is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
Low PEG Ratio: Insufficient data to calculate STNN's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: STNN is overvalued based on its PB Ratio (36.8x) compared to the US Pharmaceuticals industry average (2.9x).
How is EPHS Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as EPHS Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of STNN’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access EPHS Holdings's filings and announcements here.
- Explore growth companies in the Pharmaceuticals & Biotech industry.
How has EPHS Holdings performed over the past 5 years?
Last years earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: STNN is unprofitable, and there is insufficient past data to establish if their past 5-year earnings growth rate was positive.
Accelerating Growth: Unable to compare STNN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: STNN is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (24.3%).
Return on Equity
High ROE: STNN has a negative Return on Equity (-278.97%), as it is currently unprofitable.
Return on Assets
ROA vs Industry: STNN is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: STNN is currently unprofitable, so its Return on Capital Employed is negative.
How is EPHS Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: STNN's short term assets ($175.9K) do not cover its short term liabilities ($629.5K)
Long Term Liabilities: STNN's short term assets (175.9K) do not cover its long term liabilities (1.6M)
Debt to Equity History and Analysis
Debt Level: STNN's debt to equity ratio (195.5%) is considered high
Reducing Debt: Insufficient data to determine if STNN's debt to equity ratio has reduced over the past 5 years.
Inventory Level: STNN has a high level of physical assets or inventory.
Debt Coverage by Assets: STNN's debt is not covered by short term assets (assets are 0.1x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: STNN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: STNN has less than a year of cash runway if free cash flow continues to reduce at historical rates of -108.4% each year
What is EPHS Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate STNN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate STNN's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if STNN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if STNN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of STNN's dividend in 3 years as they are not forecast to pay a notable one for the US market.
What is the CEO of EPHS Holdings's salary, the management and board of directors tenure and is there insider trading?
EPHS Holdings has no CEO, or we have no data on them.
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
EPHS Holdings, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: EPHS Holdings, Inc.
- Ticker: STNN
- Exchange: OTCPK
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$33.485m
- Shares outstanding: 74.41m
- Website: https://www.ephsholdings.com
Number of Employees
- EPHS Holdings, Inc.
- 5490 Notre Dame Est
- H1N 2C4
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|STNN||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Feb 2018|
EPHS Holdings, Inc., through its subsidiary, Emerald Plants Health Source Inc., produces cannabis for medical use. The company is based in Montreal, Canada.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2019/10/19 00:36|
|End of Day Share Price||2019/10/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.